Metraipolis › archive › dc_442564c287d5

Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative breast cancer — Europe PMC PMID:38722825

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38722825
DOI
10.1371/journal.pgen.1011236
License (as archived)
CC0-1.0
Archived
2026-10-06T18:46:15.945Z
SHA-256 of the archived text
7bc10ef8a0bbe540d1cb78b95653ed8e1aab73903697176ba9fb0046186c1e31
Stable URL of this page
https://metraipolis.com/documento/dc_442564c287d5

How to cite

Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative breast cancer — Europe PMC PMID:38722825 — Europe PMC (en), https://europepmc.org/article/MED/38722825 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_442564c287d5 (Metraipolis archive dc_442564c287d5, sha256 7bc10ef8a0bbe540d1cb78b95653ed8e1aab73903697176ba9fb0046186c1e31)
BibTeX
@misc{dc442564c287d5,
  title = {Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative breast cancer — Europe PMC PMID:38722825},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38722825},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_442564c287d5; sha256 7bc10ef8a0bbe540d1cb78b95653ed8e1aab73903697176ba9fb0046186c1e31},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38722825. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Patients with ER-negative breast cancer have the worst prognosis of all breast cancer subtypes, often experiencing rapid recurrence or progression to metastatic disease shortly after diagnosis. Given that metastasis is the primary cause of mortality in most solid tumors, understanding metastatic biology is crucial for effective intervention. Using a mouse systems genetics approach, we previously identified 12 genes associated with metastatic susceptibility. Here, we extend those studies to identify Resf1, a poorly characterized gene, as a novel metastasis susceptibility gene in ER- breast cancer. Resf1 is a large, unstructured protein with an evolutionarily conserved intron-exon structure, but with poor amino acid conservation. CRISPR or gene trap mouse models crossed to the Polyoma Middle-T antigen genetically engineered mouse model (MMTV-PyMT) demonstrated that reduction of Resf1 resulted in a significant increase in tumor growth, a shortened overall survival time, and increased incidence and number of lung metastases, consistent with patient data. Furthermore, an analysis of matched tail and primary tissues revealed loss of the wildtype copy in tumor tissue, consistent with Resf1 being a tumor suppressor. Mechanistic analysis revealed a potential role of Resf1 in transcriptional control through association with compound G4 quadruplexes in expressed sequences, particularly those associated with ribosomal biogenesis. These results suggest that loss of Resf1 enhances tumor progression in ER- breast cancer through multiple alterations in both transcriptional and translational control.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS genetics, 2024 (prima pubblicazione 2024-05-09).
Identificativi: PMID 38722825 · PMCID PMC11081379 · DOI 10.1371/journal.pgen.1011236.
Descrittori MeSH principali: Repressor Proteins; Triple Negative Breast Neoplasms.
Pagina: https://europepmc.org/article/MED/38722825 — https://doi.org/10.1371/journal.pgen.1011236. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T17:12:53.146Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.